HomeCYTO • CVE
add
Cytophage Technologies Ltd
Previous close
$0.27
Day range
$0.28 - $0.28
Year range
$0.22 - $0.76
Market cap
14.83M CAD
Avg Volume
43.48K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.10M | 13.14% |
Net income | -1.09M | -11.74% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -989.46K | -14.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.36M | — |
Total assets | 6.14M | — |
Total liabilities | 1.96M | — |
Total equity | 4.17M | — |
Shares outstanding | 53.94M | — |
Price to book | 3.38 | — |
Return on assets | -40.97% | — |
Return on capital | -43.52% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.09M | -11.74% |
Cash from operations | -866.30K | -4.59% |
Cash from investing | -363.65K | -912.30% |
Cash from financing | -74.62K | -142.48% |
Net change in cash | -1.30M | -89.48% |
Free cash flow | -915.29K | — |
About
Headquarters
Website
